Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jan 15, 2024; 16(1): 144-181
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.144
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.144
Figure 3 Pyruvate dehydrogenase E1 subunit β expression in the UACLAN and HPA databases.
A: Breast invasive carcinoma; B: Colon adenocarcinoma; C: Kidney renal clear cell carcinoma; D: Liver hepatocellular carcinoma; E: Lung adenocarcinoma; F: Thyroid carcinoma; G: Uterine corpus endometrial carcinoma. BRCA: Breast invasive carcinoma; COAD: Colon adenocarcinoma; KIRC: Kidney renal clear cell carcinoma; LIHC: Liver hepatocellular carcinoma; LUAD: Lung adenocarcinoma; THCA: Thyroid carcinoma; UCEC: Uterine corpus endometrial carcinoma.
- Citation: Rong Y, Liu SH, Tang MZ, Wu ZH, Ma GR, Li XF, Cai H. Analysis of the potential biological value of pyruvate dehydrogenase E1 subunit β in human cancer. World J Gastrointest Oncol 2024; 16(1): 144-181
- URL: https://www.wjgnet.com/1948-5204/full/v16/i1/144.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i1.144